BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23583286)

  • 1. Development of a fluorescence-based HIV-1 integrase DNA binding assay for identification of novel HIV-1 integrase inhibitors.
    Han YS; Xiao WL; Quashie PK; Mesplède T; Xu H; Deprez E; Delelis O; Pu JX; Sun HD; Wainberg MA
    Antiviral Res; 2013 Jun; 98(3):441-8. PubMed ID: 23583286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A high-throughput assay for HIV-1 integrase 3'-processing activity using time-resolved fluorescence.
    Han YS; Quashie P; Mesplede T; Xu H; Mekhssian K; Fenwick C; Wainberg MA
    J Virol Methods; 2012 Sep; 184(1-2):34-40. PubMed ID: 22584270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical screening assays to identify HIV-1 integrase inhibitors.
    Clynhens M; Smets A; Vereycken I; Van Loock M; Clayton R; Meersseman G; Goethals O
    Methods Mol Biol; 2013; 1030():25-36. PubMed ID: 23821258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reporter gene expression from LTR-circles as tool to identify HIV-1 integrase inhibitors.
    Van Loock M; Hombrouck A; Jacobs T; Winters B; Meersseman G; Van Acker K; Clayton RF; Malcolm BA
    J Virol Methods; 2013 Feb; 187(2):238-47. PubMed ID: 23178583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of a new in vitro reaction substrate reproducing both U3 and U5 regions of the HIV-1 3'-ends increases the correlation between the in vitro and in vivo effects of the HIV-1 integrase inhibitors.
    Tramontano E; Onidi L; Esposito F; Badas R; La Colla P
    Biochem Pharmacol; 2004 May; 67(9):1751-61. PubMed ID: 15081874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydroxythiophenes are novel potent inhibitors of human immunodeficiency virus integrase with a diketo acid-like pharmacophore.
    Kehlenbeck S; Betz U; Birkmann A; Fast B; Göller AH; Henninger K; Lowinger T; Marrero D; Paessens A; Paulsen D; Pevzner V; Schohe-Loop R; Tsujishita H; Welker R; Kreuter J; Rübsamen-Waigmann H; Dittmer F
    J Virol; 2006 Jul; 80(14):6883-94. PubMed ID: 16809294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to HIV-1 integrase inhibitors: A structural perspective.
    Mouscadet JF; Delelis O; Marcelin AG; Tchertanov L
    Drug Resist Updat; 2010; 13(4-5):139-50. PubMed ID: 20570551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for antiviral inhibitors of the HIV integrase-LEDGF/p75 interaction using the AlphaScreen luminescent proximity assay.
    Hou Y; McGuinness DE; Prongay AJ; Feld B; Ingravallo P; Ogert RA; Lunn CA; Howe JA
    J Biomol Screen; 2008 Jun; 13(5):406-14. PubMed ID: 18480474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human immunodeficiency virus type I integrase by naphthamidines and 2-aminobenzimidazoles.
    Middleton T; Lim HB; Montgomery D; Rockway T; Tang H; Cheng X; Lu L; Mo H; Kohlbrenner WE; Molla A; Kati WM
    Antiviral Res; 2004 Oct; 64(1):35-45. PubMed ID: 15451177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes to the HIV long terminal repeat and to HIV integrase differentially impact HIV integrase assembly, activity, and the binding of strand transfer inhibitors.
    Dicker IB; Samanta HK; Li Z; Hong Y; Tian Y; Banville J; Remillard RR; Walker MA; Langley DR; Krystal M
    J Biol Chem; 2007 Oct; 282(43):31186-96. PubMed ID: 17715137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling, analysis, and validation of a novel HIV integrase structure provide insights into the binding modes of potent integrase inhibitors.
    Chen X; Tsiang M; Yu F; Hung M; Jones GS; Zeynalzadegan A; Qi X; Jin H; Kim CU; Swaminathan S; Chen JM
    J Mol Biol; 2008 Jul; 380(3):504-19. PubMed ID: 18565342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel high-throughput cellular screening assay for the discovery of HIV-1 integrase inhibitors.
    Van Loock M; Meersseman G; Van Acker K; Van Den Eynde C; Jochmans D; Van Schoubroeck B; Dams G; Heyndrickx L; Clayton RF
    J Virol Methods; 2012 Feb; 179(2):396-401. PubMed ID: 22172974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of recombinant HIV-1 integrase on mini-HIV DNA.
    Cherepanov P; Surratt D; Toelen J; Pluymers W; Griffith J; De Clercq E; Debyser Z
    Nucleic Acids Res; 1999 May; 27(10):2202-10. PubMed ID: 10219094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The terminal (catalytic) adenosine of the HIV LTR controls the kinetics of binding and dissociation of HIV integrase strand transfer inhibitors.
    Langley DR; Samanta HK; Lin Z; Walker MA; Krystal MR; Dicker IB
    Biochemistry; 2008 Dec; 47(51):13481-8. PubMed ID: 18991395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 integrase inhibitors that compete with the target DNA substrate define a unique strand transfer conformation for integrase.
    Espeseth AS; Felock P; Wolfe A; Witmer M; Grobler J; Anthony N; Egbertson M; Melamed JY; Young S; Hamill T; Cole JL; Hazuda DJ
    Proc Natl Acad Sci U S A; 2000 Oct; 97(21):11244-9. PubMed ID: 11016953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells.
    Hazuda DJ; Felock P; Witmer M; Wolfe A; Stillmock K; Grobler JA; Espeseth A; Gabryelski L; Schleif W; Blau C; Miller MD
    Science; 2000 Jan; 287(5453):646-50. PubMed ID: 10649997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interactions of HIV-1 DNA heterocyclic bases with viral DNA].
    Agapkina IuIu; Tashlitskiĭ VN; Deprez E; Brochon JC; Shugaliĭ AV; Mouscadet JF; Gottikh MB
    Mol Biol (Mosk); 2004; 38(5):848-57. PubMed ID: 15554187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel virtual screening protocol based on the combined use of molecular modeling and electron-ion interaction potential techniques to design HIV-1 integrase inhibitors.
    Tintori C; Manetti F; Veljkovic N; Perovic V; Vercammen J; Hayes S; Massa S; Witvrouw M; Debyser Z; Veljkovic V; Botta M
    J Chem Inf Model; 2007; 47(4):1536-44. PubMed ID: 17608406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The naphthyridinone GSK364735 is a novel, potent human immunodeficiency virus type 1 integrase inhibitor and antiretroviral.
    Garvey EP; Johns BA; Gartland MJ; Foster SA; Miller WH; Ferris RG; Hazen RJ; Underwood MR; Boros EE; Thompson JB; Weatherhead JG; Koble CS; Allen SH; Schaller LT; Sherrill RG; Yoshinaga T; Kobayashi M; Wakasa-Morimoto C; Miki S; Nakahara K; Noshi T; Sato A; Fujiwara T
    Antimicrob Agents Chemother; 2008 Mar; 52(3):901-8. PubMed ID: 18160521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro assays for activities of retroviral integrase.
    Chow SA
    Methods; 1997 Aug; 12(4):306-17. PubMed ID: 9245611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.